Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer

References

• SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
   PubMed Web of Science ®Google Scholar
• PennathurAGibsonMKJobeBALuketichJDOesophageal carcinomaLancet2013381986440041223374478
   PubMed Web of Science ®Google Scholar
• CooperJSGuoMDHerskovicAChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology GroupJAMA1999281171623162710235156
   PubMed Web of Science ®Google Scholar
• HerskovicAMartzKal-SarrafMCombined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagusN Engl J Med199232624159315981584260
   PubMed Web of Science ®Google Scholar
• MinskyBDPajakTFGinsbergRJINT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapyJ Clin Oncol20022051167117411870157
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer NetworkEsophageal and Esoph-agogastric Junction CancersNational Comprehensive Cancer Network2015 Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
   Google Scholar
• WelshJSettleSHAminiAFailure patterns in patients with esophageal cancer treated with definitive chemoradiationCancer2012118102632264022565611
   PubMed Web of Science ®Google Scholar
• ChandraAGuerreroTMLiuHHFeasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancerRadiother Oncol200577324725316298001
   PubMed Web of Science ®Google Scholar
• FenkellLKaminskyIBreenSHuangSVan ProoijenMRingashJDosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagusRadiother Oncol200889328729118789828
   PubMed Web of Science ®Google Scholar
• LeclercMMaingonPHamoirMA dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approachRadiother Oncol2013106333334023541643
   PubMed Web of Science ®Google Scholar
• YuWWZhuZFFuXLSimultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II studyStrahlenther Onkol20141901197998624609941
   PubMed Web of Science ®Google Scholar
• YuWCaiXWLiuQSafety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancerRadiother Oncol2015114219520025586952
   PubMed Web of Science ®Google Scholar
• ChenJGuoHZhaiTRadiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II studyOncotarget2016716227112271926992206
   PubMedGoogle Scholar
• ZhangWZChenJZLiDRSimultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility studyWorld J Gastroenterol20142038139731398025320535
   PubMedGoogle Scholar
• WelshJPalmerMBAjaniJAEsophageal cancer dose escalation using a simultaneous integrated boost techniqueInt J Radiat Oncol Biol Phys201282146847421123005
   PubMed Web of Science ®Google Scholar
• WarrenSPartridgeMCarringtonRHurtCCrosbyTHawkinsMARadiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancerInt J Radiat Oncol Biol Phys201490242342925304796
   PubMedGoogle Scholar
• HiguchiKKomoriSTanabeSDefinitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2)Int J Radiat Oncol Biol Phys201489487287924867539
   PubMed Web of Science ®Google Scholar
• RoederFNicolayNHNguyenTIntensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancerRadiat Oncol2014919125175056
   PubMed Web of Science ®Google Scholar
• KuangYWuLHirataEMiyazakiKSatoMKweeSAVolumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CTInt J Radiat Oncol Biol Phys20159151017102525832692
   PubMedGoogle Scholar
• KongFMRitterTQuintDJConsideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexusInt J Radiat Oncol Biol Phys20118151442145720934273
   PubMed Web of Science ®Google Scholar
• CaglarHBOthusMAllenAMEsophagus in-field: a new predictor for esophagitisRadiother Oncol2010971485320832884
   PubMed Web of Science ®Google Scholar
• KwintMUyterlindeWNijkampJAcute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapyInt J Radiat Oncol Biol Phys2012842e223e22822560551
   PubMed Web of Science ®Google Scholar
• WijsmanRDankersFTroostEGMultivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapyRadiother Oncol20151171495426341608
   PubMed Web of Science ®Google Scholar
• LuJYCheungMLHuangBTImproving target coverage and organ-at-risk sparing in intensity-modulated radiotherapy for cervical oesophageal cancer using a simple optimisation methodPLoS One2015103e012167925768733
   PubMedGoogle Scholar
• GehJIBondSJBentzenSMGlynne-JonesRSystematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose responseRadiother Oncol200678323624416545878
   PubMed Web of Science ®Google Scholar
• WebbSNahumAEA model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell densityPhys Med Biol19933866536668346278
   PubMedGoogle Scholar
• BedfordJLViviersLGuzelZChildsPJWebbSTaitDMA quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagusRadiother Oncol200057218319311054522
   PubMedGoogle Scholar
• OkunieffPMorganDNiemierkoASuitHDRadiation dose-response of human tumorsInt J Radiat Oncol Biol Phys1995324122712377607946
   PubMedGoogle Scholar
• SeppenwooldeYLebesqueJVde JaegerKComparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probabilityInt J Radiat Oncol Biol Phys200355372473512573760
   PubMed Web of Science ®Google Scholar
• BurmanCKutcherGJEmamiBGoiteinMFitting of normal tissue tolerance data to an analytic functionInt J Radiat Oncol Biol Phys19912111231352032883
   PubMed Web of Science ®Google Scholar
• ChenCUyterlindeWSonkeJJde BoisJvan den HeuvelMBelderbosJSevere late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapyRadiother Oncol2013108233734124074814
   PubMedGoogle Scholar
• HuangBTLuJYLinPXChenJZLiDRChenCZRadiobiologi-cal modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapySci Rep201551801026657569
   PubMed Web of Science ®Google Scholar
• AuperinALe PechouxCRollandEMeta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancerJ Clin Oncol201028132181219020351327
   PubMed Web of Science ®Google Scholar
• RoseJRodriguesGYaremkoBLockMD’SouzaDSystematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapyRadiother Oncol200991328228718950881
   PubMed Web of Science ®Google Scholar
• Bar-AdVOhriNWerner-WasikMEsophagitis, treatment-related toxicity in non-small cell lung cancerRev Recent Clin Trials201271313521864251
   PubMedGoogle Scholar
• UyterlindeWChenCKwintMPrognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancerRadiother Oncol2013107339239723647749
   PubMed Web of Science ®Google Scholar
• PalmaDASenanSOberijeCPredicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysisInt J Radiat Oncol Biol Phys201387469069624035329
   PubMed Web of Science ®Google Scholar
• ZhangZXuJZhouTRisk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapyRadiat Oncol201495424528546
   PubMed Web of Science ®Google Scholar
• ZehentmayrFSohnMExeliAKNormal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)Radiat Oncol20151012126018527
   PubMedGoogle Scholar
• GomezDRTuckerSLMartelMKPredictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancerInt J Radiat Oncol Biol Phys20128441010101622920974
   PubMedGoogle Scholar
• HuangEXBradleyJDEl NaqaIModeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patientsInt J Radiat Oncol Biol Phys20128251674167921658856
   PubMed Web of Science ®Google Scholar
• ZhuJZhangZCLiBSAnalysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP modelRadiother Oncol201097344945421067834
   PubMed Web of Science ®Google Scholar